Latest News

Stay up to date with the latest stock market news from around the world. From breaking news written by our finance analysts to event-driven market news on a global scale.

NasdaqGS:IQ
NasdaqGS:IQEntertainment

Will Hong Kong Listing, Buyback and AI Push Change iQIYI's (IQ) Investment Narrative?

In late March 2026, iQIYI, Inc. outlined several corporate moves, including a proposed Main Board listing on the Hong Kong Stock Exchange, board approval of a new US$100 million share repurchase program over 18 months, and the start of open commercial testing for its Nadou Pro AI agents for professional long-form video generation. Together, the Hong Kong listing plan, buyback authorization, and AI video initiative highlight how iQIYI is simultaneously pursuing broader capital access, capital...
NYSE:DHR
NYSE:DHRLife Sciences

Is Danaher’s BIO-Europe Spring Focus Sharpening Its Life Sciences Edge or Simply Polishing the Story (DHR)?

Danaher Corporation recently presented at the BIO-Europe Spring 2026 conference in Lisbon on March 24, 2026, with Senior Director Luciano Lucas speaking to an audience focused on biopharma partnering and innovation. This appearance gives Danaher a platform to highlight its life sciences tools and diagnostics capabilities to prospective collaborators and customers in a highly specialized setting. We’ll now examine how Danaher’s BIO-Europe Spring presentation, emphasizing its life sciences and...
BIT:G
BIT:GInsurance

Assessing Assicurazioni Generali (BIT:G) Valuation After Its Higher Annual Dividend Announcement

Dividend announcement and what it means for Assicurazioni Generali (BIT:G) Assicurazioni Generali (BIT:G) has announced an annual dividend of €1.6400 per share, payable on 20 May 2026, with an ex dividend date of 18 May and record date of 19 May. For investors, this dividend decision puts fresh attention on the stock’s income profile, overall payout level, and how that fits with recent share performance and earnings trends. See our latest analysis for Assicurazioni Generali. The latest annual...
XTRA:TIMA
XTRA:TIMAHospitality

ZEAL Network (XTRA:TIMA) Valuation After 2025 Earnings Reveal Sales Growth With Weaker Profitability

ZEAL Network earnings trigger fresh look at profitability ZEAL Network (XTRA:TIMA) has released full year 2025 results, reporting sales of €218.45 million compared with €188.2 million a year earlier. Net income and earnings per share were lower than in the prior year. See our latest analysis for ZEAL Network. At a share price of €48.8, ZEAL Network’s recent 1-day and 7-day share price gains contrast with weaker 30 and 90 day share price returns. However, longer term total shareholder returns...
NasdaqGS:JKHY
NasdaqGS:JKHYDiversified Financial

A Look At Jack Henry & Associates (JKHY) Valuation After New Zelle Partnership And Community Bank Wins

Jack Henry & Associates (JKHY) is back in focus after Zelle expanded its Minority Depository Institution access program through a new partnership with the fintech provider, and Independent Bancshares Inc. selected Jack Henry to upgrade its core technology. See our latest analysis for Jack Henry & Associates. Despite the recent Zelle expansion and new bank wins, Jack Henry & Associates' 1-day share price return of 2.04% comes after a weaker patch, with a 90-day share price return of a 15.24%...
NYSE:SPCE
NYSE:SPCEAerospace & Defense

A Look At Virgin Galactic (SPCE) Valuation After Appointing A New Chief Growth Officer

Virgin Galactic Holdings (SPCE) has created a new Chief Growth Officer role and appointed Megan Prichard. She has been tasked with leading revenue and expansion efforts across spaceflight expeditions, research missions, spaceports, partnerships, and new commercial markets. See our latest analysis for Virgin Galactic Holdings. The share price has retreated to US$2.17, with a 30 day share price return of a 14.90% decline and a 34.24% decline over 90 days. The 5 year total shareholder return of...
NasdaqGS:RARE
NasdaqGS:RAREBiotechs

A Look At Ultragenyx Pharmaceutical (RARE) Valuation After FDA Clears UX016 For GNE Myopathy

Ultragenyx Pharmaceutical (RARE) recently reported that the U.S. Food and Drug Administration cleared its Investigational New Drug application for UX016, a potential substrate replacement therapy for GNE myopathy, and a Phase 1/2 study is planned for 2026. See our latest analysis for Ultragenyx Pharmaceutical. Despite the UX016 milestone, the recent 30 day share price return of 17.49% decline and year to date share price return of 18.22% decline sit against a 1 year total shareholder return...
SEHK:2356
SEHK:2356Banks

Dah Sing Banking Group (SEHK:2356) Is Up 7.4% After Stronger 2025 Earnings Per Share Results - Has The Bull Case Changed?

Dah Sing Banking Group Limited has reported its full-year 2025 results, with net interest income rising to HK$5,828.67 million and net income reaching HK$2,475.81 million, alongside higher basic and diluted earnings per share from continuing operations compared with the prior year. The earnings release highlights stronger profitability per share, suggesting improved efficiency in converting revenue into shareholder earnings across Dah Sing Banking Group’s core banking operations. Next, we...
NYSE:GME
NYSE:GMESpecialty Retail

How GameStop’s Higher Profits Amid Falling Sales Will Impact GameStop (GME) Investors

GameStop Corp. recently reported results for the fourth quarter and full year ended January 31, 2026, with quarterly sales of US$1,104.3 million versus US$1,282.6 million a year earlier and quarterly net income of US$127.9 million versus US$131.3 million. Despite lower sales both in the quarter and across the full year, full-year net income rose to US$418.4 million, lifting earnings per share from continuing operations compared with the prior year. Next, we’ll examine how GameStop’s higher...
SHSE:688531
SHSE:688531Electronic

High Growth Tech Stocks In Asia To Watch This March 2026

As geopolitical tensions and energy price volatility continue to shape market sentiment, Asian tech stocks are navigating a complex landscape with potential for high growth. In this environment, a good stock is often characterized by its ability to adapt to external pressures, maintain robust innovation pipelines, and capitalize on regional economic trends.
SHSE:605499
SHSE:605499Beverage

3 Asian Stocks Estimated To Be Trading At Up To 37.5% Below Intrinsic Value

As geopolitical tensions and energy price volatility continue to influence global markets, Asian equities have not been immune to these pressures. Despite these challenges, opportunities may exist for investors seeking undervalued stocks that are trading below their intrinsic value. In such a climate, identifying stocks with strong fundamentals and potential for growth can be key to navigating uncertain market conditions.
SHSE:688167
SHSE:688167Semiconductor

3 Asian Growth Companies With High Insider Ownership Growing Revenues Up To 24%

In the current landscape, Asian markets are navigating through challenges posed by energy price volatility and geopolitical tensions, which have influenced investor sentiment and economic forecasts. Amid these conditions, companies with strong insider ownership often demonstrate resilience and alignment of interests between management and shareholders, making them appealing to investors seeking growth opportunities.
SHSE:600094
SHSE:600094Real Estate

Asian Penny Stocks To Watch In March 2026

As March 2026 unfolds, the Asian markets are navigating through a landscape marked by energy price volatility and geopolitical tensions in the Middle East. This backdrop has created both challenges and opportunities for investors, particularly those interested in exploring less conventional avenues like penny stocks. Though often associated with smaller or newer companies, penny stocks remain relevant for their potential to uncover hidden value when supported by strong financials. In this...
TWSE:3167
TWSE:3167Electronic

Exploring Shanghai Skychem Technology and Two Other Undiscovered Asian Gems

Amidst the backdrop of geopolitical tensions and volatile energy prices, Asian markets are navigating a complex landscape, with small-cap indices like the S&P MidCap 400 showing resilience by snapping recent losing streaks. In this environment, discerning investors often look for stocks that combine strong fundamentals with growth potential in sectors less impacted by global uncertainties.
SEHK:3698
SEHK:3698Banks

Asian Dividend Stocks Yielding Up To 5.1%

As geopolitical tensions and energy price volatility continue to shape global market sentiment, Asian markets are navigating these challenges with varying impacts on their economies and stock performances. In this complex environment, dividend stocks in Asia stand out as a potential source of steady income, offering investors a degree of stability amid market fluctuations.
NYSE:AA
NYSE:AAMetals and Mining

Middle East Supply Shock Puts Alcoa Margins And Valuation In Focus

Missile attacks on major Middle East aluminum producers have disrupted material supply and pushed aluminum prices higher in recent days. These disruptions are drawing fresh attention to US based producer Alcoa (NYSE:AA) as investors reassess supply risk and potential margin effects. The renewed focus comes after earlier commentary around aluminum markets centered on easing supply and related price pressure. For Alcoa at a share price of $63.22, the new supply shock lands on top of a strong...
NYSE:USAC
NYSE:USACEnergy Services

Is It Too Late To Consider USA Compression Partners (USAC) After Strong Multi‑Year Returns?

If you are wondering whether USA Compression Partners at around US$27.29 is priced attractively or not, the key is to separate share price excitement from underlying value. The unit price is down 2.4% over the last 7 days and 0.1% over the last 30 days, yet it still shows a 14.7% return year to date and 10.3% over the past year, with longer term returns of 66.1% over 3 years and 207.2% over 5 years. These moves sit against a backdrop of ongoing interest in energy infrastructure partnerships...
NasdaqGS:CLBT
NasdaqGS:CLBTSoftware

Assessing Cellebrite DI (CLBT) Valuation After Global Launch Of Guardian Investigate

Guardian Investigate launch puts Cellebrite DI (CLBT) in focus Cellebrite DI (NasdaqGS:CLBT) is drawing fresh attention after launching Guardian Investigate worldwide, an AI-powered case management tool designed to help law enforcement teams organize, analyze and collaborate on complex digital investigations. See our latest analysis for Cellebrite DI. The Guardian Investigate launch comes after a mixed period for the stock, with a 1-day share price return of 2.16% to US$13.23, a 90-day share...
NYSE:MRK
NYSE:MRKPharmaceuticals

Merck Cardiovascular Readouts Point To New Growth Drivers Beyond Oncology

Merck (NYSE:MRK) reported positive Phase 3 results for its oral PCSK9 inhibitor, enlicitide decanoate, showing marked LDL C reduction and a favorable safety profile. The company also released Phase 2 WINREVAIR data in combined post and precapillary pulmonary hypertension with heart failure, supporting further clinical development. These readouts highlight potential franchise expansion for Merck in cardiovascular and cardiopulmonary diseases, extending beyond its existing oncology focus. For...
NYSE:WS
NYSE:WSMetals and Mining

Worthington Steel (WS) Is Down 12.0% After Mixed Q3 Results And Dividend Declaration Has The Bull Case Changed?

Worthington Steel, Inc. has already reported its third-quarter and nine-month results to February 28, 2026, showing higher sales of US$769.8 million for the quarter and US$2.51 billion for nine months, but with quarterly net income easing to US$10.4 million while nine‑month earnings improved to US$66 million; the board also declared a US$0.16 per‑share dividend payable on June 26, 2026. The mix of rising revenue but softer quarterly profitability, alongside a maintained dividend, highlights...